Global Cell-Free DNA (cfDNA) Testing Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 107
Inquire Before Buying

Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.

Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.

Market Analysis and Insights: Global Cell-Free DNA (cfDNA) Testing Market

The global Cell-Free DNA (cfDNA) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell-Free DNA (cfDNA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell-Free DNA (cfDNA) Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell-Free DNA (cfDNA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell-Free DNA (cfDNA) Testing market.

Global Cell-Free DNA (cfDNA) Testing Scope and Market Size

Cell-Free DNA (cfDNA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell-Free DNA (cfDNA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Donor-Derived Cell-Free DNA (DdcfDNA)

- Circulating Cell-Free Tumor DNA (CtDNA)

- Cell-Free Fetal DNA (NIPT)

Segment by Application

- Hospital

- Ambulatory Surgical Centers

- Cancer Research Institutes

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Agilent Technology

- Allenex

- Biocept

- Biodesix

- CareDx

- Guardant Health

- Illumania

- Invited

- Natera

- Quest Diagnostics

- Roche Holdings

- Sequenom

- Trovagene

Global Cell-Free DNA (cfDNA) Testing Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
1.2.4 Cell-Free Fetal DNA (NIPT)
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2016-2027)
2.2 Cell-Free DNA (cfDNA) Testing Growth Trends by Regions
2.2.1 Cell-Free DNA (cfDNA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cell-Free DNA (cfDNA) Testing Industry Dynamic
2.3.1 Cell-Free DNA (cfDNA) Testing Market Trends
2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2016-2021)
3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2020
3.5 Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2016-2021)
4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2022-2027)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2016-2021)
5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2016-2027)
6.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Type
6.2.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021)
6.2.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027)
6.2.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2027)
6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Application
6.3.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021)
6.3.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027)
6.3.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2027)
6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country
6.4.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021)
6.4.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2016-2027)
7.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type
7.2.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021)
7.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027)
7.2.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2027)
7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application
7.3.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021)
7.3.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027)
7.3.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2027)
7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country
7.4.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021)
7.4.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2016-2027)
8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type
8.2.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application
8.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region
8.4.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2016-2027)
9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type
9.2.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2027)
9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application
9.3.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2027)
9.4 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country
9.4.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2016-2027)
10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type
10.2.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application
10.3.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country
10.4.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Details
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.1.5 Agilent Technology Recent Development
11.2 Allenex
11.2.1 Allenex Company Details
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.2.5 Allenex Recent Development
11.3 Biocept
11.3.1 Biocept Company Details
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.3.5 Biocept Recent Development
11.4 Biodesix
11.4.1 Biodesix Company Details
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.4.5 Biodesix Recent Development
11.5 CareDx
11.5.1 CareDx Company Details
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.5.5 CareDx Recent Development
11.6 Guardant Health
11.6.1 Guardant Health Company Details
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.6.5 Guardant Health Recent Development
11.7 Illumania
11.7.1 Illumania Company Details
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.7.5 Illumania Recent Development
11.8 Invited
11.8.1 Invited Company Details
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.8.5 Invited Recent Development
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.9.5 Natera Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.10.5 Quest Diagnostics Recent Development
11.11 Roche Holdings
11.11.1 Roche Holdings Company Details
11.11.2 Roche Holdings Business Overview
11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.11.5 Roche Holdings Recent Development
11.12 Sequenom
11.12.1 Sequenom Company Details
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.12.5 Sequenom Recent Development
11.13 Trovagene
11.13.1 Trovagene Company Details
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Regions (2016-2021)
Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Regions (2022-2027)
Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2016-2021)
Table 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2020)
Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
Table 22. Date of Enter into Cell-Free DNA (cfDNA) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Agilent Technology Company Details
Table 63. Agilent Technology Business Overview
Table 64. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
Table 65. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 66. Agilent Technology Recent Development
Table 67. Allenex Company Details
Table 68. Allenex Business Overview
Table 69. Allenex Cell-Free DNA (cfDNA) Testing Product
Table 70. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 71. Allenex Recent Development
Table 72. Biocept Company Details
Table 73. Biocept Business Overview
Table 74. Biocept Cell-Free DNA (cfDNA) Testing Product
Table 75. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 76. Biocept Recent Development
Table 77. Biodesix Company Details
Table 78. Biodesix Business Overview
Table 79. Biodesix Cell-Free DNA (cfDNA) Testing Product
Table 80. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 81. Biodesix Recent Development
Table 82. CareDx Company Details
Table 83. CareDx Business Overview
Table 84. CareDx Cell-Free DNA (cfDNA) Testing Product
Table 85. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 86. CareDx Recent Development
Table 87. Guardant Health Company Details
Table 88. Guardant Health Business Overview
Table 89. Guardant Health Cell-Free DNA (cfDNA) Testing Product
Table 90. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 91. Guardant Health Recent Development
Table 92. Illumania Company Details
Table 93. Illumania Business Overview
Table 94. Illumania Cell-Free DNA (cfDNA) Testing Product
Table 95. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 96. Illumania Recent Development
Table 97. Invited Company Details
Table 98. Invited Business Overview
Table 99. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 100. Invited Recent Development
Table 101. Natera Company Details
Table 102. Natera Business Overview
Table 103. Natera Cell-Free DNA (cfDNA) Testing Product
Table 104. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 105. Natera Recent Development
Table 106. Quest Diagnostics Company Details
Table 107. Quest Diagnostics Business Overview
Table 108. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
Table 109. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 110. Quest Diagnostics Recent Development
Table 111. Roche Holdings Company Details
Table 112. Roche Holdings Business Overview
Table 113. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
Table 114. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 115. Roche Holdings Recent Development
Table 116. Sequenom Company Details
Table 117. Sequenom Business Overview
Table 118. Sequenom Cell-Free DNA (cfDNA) Testing Product
Table 119. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 120. Sequenom Recent Development
Table 121. Trovagene Company Details
Table 122. Trovagene Business Overview
Table 123. Trovagene Cell-Free DNA (cfDNA) Testing Product
Table 124. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2016-2021) & (US$ Million)
Table 125. Trovagene Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2020 VS 2027
Figure 2. Donor-Derived Cell-Free DNA (DdcfDNA) Features
Figure 3. Circulating Cell-Free Tumor DNA (CtDNA) Features
Figure 4. Cell-Free Fetal DNA (NIPT) Features
Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Cell-Free DNA (cfDNA) Testing Report Years Considered
Figure 10. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Share by Regions (2022-2027)
Figure 14. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2020
Figure 15. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2020
Figure 17. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cell-Free DNA (cfDNA) Testing Market Share by Type (2016-2027)
Figure 21. North America Cell-Free DNA (cfDNA) Testing Market Share by Application (2016-2027)
Figure 22. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2016-2027)
Figure 23. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell-Free DNA (cfDNA) Testing Market Share by Type (2016-2027)
Figure 27. Europe Cell-Free DNA (cfDNA) Testing Market Share by Application (2016-2027)
Figure 28. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2016-2027)
Figure 29. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Region (2016-2027)
Figure 39. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Type (2016-2027)
Figure 47. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Application (2016-2027)
Figure 48. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2016-2027)
Figure 49. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Country (2016-2027)
Figure 55. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 59. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 60. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 61. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 62. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 63. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 64. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 65. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 66. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 67. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 68. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 69. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 70. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs